Compare Toronto-Dominion Bank (TD) vs Health Care Select Sector SPDR Fund (XLV) Price & Performance

TD stock trades at $120.53, down 2.48% today, with a bearish technical signal despite recent earnings beats. The company reported strong Q1 2026 EPS of $1.74, beating expectations of $1.63, continuing a pattern of positive surprises. Revenue growth remains steady, climbing from $56.3B in 2024 to $61.3B in 2025. Analyst consensus is bullish with a $153 price target, though technical indicators show mixed signals with RSI neutral and ADX suggesting weakening trend strength.

TD presents a compelling value opportunity with a P/E of 20.08 and strong profitability metrics including 23.38% net income margin. However, investors face risks from volatile cash flow patterns and increasing debt-to-asset ratios. The stock's 27% upside to analyst targets and consistent dividend payments provide support, but macroeconomic sensitivity and regulatory scrutiny require careful monitoring.

XLV trades at $159.25, down 1.14% with neutral technical signals overall. The healthcare ETF shows mixed momentum with bullish moving averages but neutral oscillators. Recent news highlights XLV's defensive characteristics amid market volatility, with State Street upgrading healthcare to positive for Q3 2026. The fund's diversified approach offers stability compared to more volatile biotech-focused alternatives.

XLV presents a defensive opportunity with lower costs and steady performance, though upside may be limited in the current cycle. Key risks include patent cliff concerns and sector rotation away from defensive plays if market sentiment improves. The ETF's broad healthcare exposure provides cushion against individual stock volatility while benefiting from pipeline innovations.